These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
58 related articles for article (PubMed ID: 1436243)
1. Cytochemical study of activated peritoneal macrophages in normal and tumor-bearing rats. Klobusická M; Kusenda J Neoplasma; 1992; 39(5):291-7. PubMed ID: 1436243 [TBL] [Abstract][Full Text] [Related]
2. Tumoricidal properties of rat peritoneal macrophages activated with various activators depend on nitrogen oxid synthesis. Kusenda J; Kalafut F; Klobusická M; Novotná L Neoplasma; 1992; 39(1):15-21. PubMed ID: 1528300 [TBL] [Abstract][Full Text] [Related]
3. In vitro activation of tumoricidal properties of rat peritoneal macrophages using lipopolysaccharide. Kalafut F; Kusenda J; Klobusická M; Novotná L Neoplasma; 1990; 37(4):405-14. PubMed ID: 2234202 [TBL] [Abstract][Full Text] [Related]
4. Tumor necrosis factor as a potent effector molecule for tumor cell killing by activated rat peritoneal macrophages in vitro. Kusenda J; Kalafut F; Klobusická M; Novotná L Neoplasma; 1992; 39(1):23-8. PubMed ID: 1528301 [TBL] [Abstract][Full Text] [Related]
5. The induction and augmentation of macrophage tumoricidal responses by platelet-activating factor. Howard AD; Erickson KL Cell Immunol; 1995 Aug; 164(1):105-12. PubMed ID: 7634340 [TBL] [Abstract][Full Text] [Related]
6. Tumor target-derived soluble factor synergizes with IFN-gamma and IL-2 to activate macrophages for tumor necrosis factor and nitric oxide production to mediate cytotoxicity of the same target. Jiang H; Stewart CA; Fast DJ; Leu RW J Immunol; 1992 Sep; 149(6):2137-46. PubMed ID: 1517576 [TBL] [Abstract][Full Text] [Related]
7. Identification and characterization of monoclonal antibodies specific for macrophages at intermediate stages in the tumoricidal activation pathway. Paulnock DM; Lambert LE J Immunol; 1990 Jan; 144(2):765-73. PubMed ID: 2104906 [TBL] [Abstract][Full Text] [Related]
8. Potentiation of lymphokine-induced macrophage activation by tumor necrosis factor-alpha. Heidenreich S; Weyers M; Gong JH; Sprenger H; Nain M; Gemsa D J Immunol; 1988 Mar; 140(5):1511-8. PubMed ID: 3126228 [TBL] [Abstract][Full Text] [Related]
9. Role of tumor necrosis factor and interleukin 1 in gamma-interferon-promoted activation of mouse tumoricidal macrophages. Hori K; Mihich E; Ehrke MJ Cancer Res; 1989 May; 49(10):2606-14. PubMed ID: 2496917 [TBL] [Abstract][Full Text] [Related]
10. Tumoricidal activation of murine resident peritoneal macrophages by interleukin 2 and tumor necrosis factor alpha. Verstovsek S; Maccubbin D; Ehrke MJ; Mihich E Cancer Res; 1992 Jul; 52(14):3880-5. PubMed ID: 1617664 [TBL] [Abstract][Full Text] [Related]
11. IFN-gamma and IFN-beta independently stimulate the expression of lipopolysaccharide-inducible genes in murine peritoneal macrophages. Hamilton TA; Bredon N; Ohmori Y; Tannenbaum CS J Immunol; 1989 Apr; 142(7):2325-31. PubMed ID: 2494257 [TBL] [Abstract][Full Text] [Related]
12. Regulation of macrophage activation by IL-3. II. IL-3 and lipopolysaccharide act synergistically in the regulation of IL-1 expression. Frendl G; Fenton MJ; Beller DI J Immunol; 1990 May; 144(9):3400-10. PubMed ID: 2109777 [TBL] [Abstract][Full Text] [Related]
13. Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. Comparison of activating cytokines and evidence for independent production. Ding AH; Nathan CF; Stuehr DJ J Immunol; 1988 Oct; 141(7):2407-12. PubMed ID: 3139757 [TBL] [Abstract][Full Text] [Related]
14. Neuroprotective effects of cyclooxygenase-2 inhibitor celecoxib against toxicity of LPS-stimulated macrophages toward motor neurons. Huang Y; Liu J; Wang LZ; Zhang WY; Zhu XZ Acta Pharmacol Sin; 2005 Aug; 26(8):952-8. PubMed ID: 16038627 [TBL] [Abstract][Full Text] [Related]
15. Involvement of protein kinase C and not of NF kappa B in the modulation of macrophage nitric oxide synthase by tumor-derived phosphatidyl serine. Calderon CL; Torroella-Kouri M; Dinapoli MR; Lopez DM Int J Oncol; 2008 Mar; 32(3):713-21. PubMed ID: 18292949 [TBL] [Abstract][Full Text] [Related]
16. Leishmania major amastigotes initiate the L-arginine-dependent killing mechanism in IFN-gamma-stimulated macrophages by induction of tumor necrosis factor-alpha. Green SJ; Crawford RM; Hockmeyer JT; Meltzer MS; Nacy CA J Immunol; 1990 Dec; 145(12):4290-7. PubMed ID: 2124240 [TBL] [Abstract][Full Text] [Related]
17. Regulation of activated macrophage antimicrobial activities. Identification of lymphokines that cooperate with IFN-gamma for induction of resistance to infection. Belosevic M; Davis CE; Meltzer MS; Nacy CA J Immunol; 1988 Aug; 141(3):890-6. PubMed ID: 3135315 [TBL] [Abstract][Full Text] [Related]
18. IL-10 inhibits cytokine production by activated macrophages. Fiorentino DF; Zlotnik A; Mosmann TR; Howard M; O'Garra A J Immunol; 1991 Dec; 147(11):3815-22. PubMed ID: 1940369 [TBL] [Abstract][Full Text] [Related]
19. The glycosyl-inositol-phosphate and dimyristoylglycerol moieties of the glycosylphosphatidylinositol anchor of the trypanosome variant-specific surface glycoprotein are distinct macrophage-activating factors. Magez S; Stijlemans B; Radwanska M; Pays E; Ferguson MA; De Baetselier P J Immunol; 1998 Feb; 160(4):1949-56. PubMed ID: 9469458 [TBL] [Abstract][Full Text] [Related]
20. Inducible expression of murine IP-10 mRNA varies with the state of macrophage inflammatory activity. Narumi S; Hamilton TA J Immunol; 1991 May; 146(9):3038-44. PubMed ID: 1901891 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]